01167.HK
Jacobio Pharmaceuticals Group Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 4.60
−0.65%Margins
Gross margin
94.4%
EBITDA margin
70.5%
EBIT margin
67.4%
Net margin
69.6%
FCF margin
74.8%
37.5%
Return on equity
27.2%
Return on assets
32.5%
Return on invested capital
0.46x
Asset turnover
HKD 642.1M
Cash from operations
HKD 2.55
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026